• Amgen Inc. v. Sanofi (written description/functional antibody claiming)
• Impression Products v. Lexmark International (Patent Exhaustion Doctrine)
• Covidien LP v. Univ. Florida Research Found. (IPR/sovereign immunity defense)
• Abbvie v. Janssen (biotech/written description/invalidity of claims to antibody genus)
• Gilead Sciences v. Natco Pharma (Hatch-Waxman/obviousness-type double patenting: prior art)
• Nautilus v. Biosig (medical device/indefiniteness/Supreme Court)